1 Study Coverage
    1.1 Hemoperfusion Product Introduction
    1.2 Market by Type
        1.2.1 Global Hemoperfusion Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Activated Carbon Adsorption
        1.2.3 Resin Adsorption
    1.3 Market by Application
        1.3.1 Global Hemoperfusion Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hepatic Encephalopathy
        1.3.3 Certain Autoimmune Diseases
        1.3.4 Drug Overdose
        1.3.5 Specific Intoxications
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Hemoperfusion Sales Estimates and Forecasts 2017-2028
    2.2 Global Hemoperfusion Revenue Estimates and Forecasts 2017-2028
    2.3 Global Hemoperfusion Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Hemoperfusion Sales by Region
        2.4.1 Global Hemoperfusion Sales by Region (2017-2022)
        2.4.2 Global Sales Hemoperfusion by Region (2023-2028)
    2.5 Global Hemoperfusion Revenue by Region
        2.5.1 Global Hemoperfusion Revenue by Region (2017-2022)
        2.5.2 Global Hemoperfusion Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Hemoperfusion Sales by Manufacturers
        3.1.1 Global Top Hemoperfusion Manufacturers by Sales (2017-2022)
        3.1.2 Global Hemoperfusion Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hemoperfusion in 2021
    3.2 Global Hemoperfusion Revenue by Manufacturers
        3.2.1 Global Hemoperfusion Revenue by Manufacturers (2017-2022)
        3.2.2 Global Hemoperfusion Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Hemoperfusion Revenue in 2021
    3.3 Global Hemoperfusion Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Hemoperfusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Hemoperfusion Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Hemoperfusion Sales by Type
        4.1.1 Global Hemoperfusion Historical Sales by Type (2017-2022)
        4.1.2 Global Hemoperfusion Forecasted Sales by Type (2023-2028)
        4.1.3 Global Hemoperfusion Sales Market Share by Type (2017-2028)
    4.2 Global Hemoperfusion Revenue by Type
        4.2.1 Global Hemoperfusion Historical Revenue by Type (2017-2022)
        4.2.2 Global Hemoperfusion Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Hemoperfusion Revenue Market Share by Type (2017-2028)
    4.3 Global Hemoperfusion Price by Type
        4.3.1 Global Hemoperfusion Price by Type (2017-2022)
        4.3.2 Global Hemoperfusion Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Hemoperfusion Sales by Application
        5.1.1 Global Hemoperfusion Historical Sales by Application (2017-2022)
        5.1.2 Global Hemoperfusion Forecasted Sales by Application (2023-2028)
        5.1.3 Global Hemoperfusion Sales Market Share by Application (2017-2028)
    5.2 Global Hemoperfusion Revenue by Application
        5.2.1 Global Hemoperfusion Historical Revenue by Application (2017-2022)
        5.2.2 Global Hemoperfusion Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Hemoperfusion Revenue Market Share by Application (2017-2028)
    5.3 Global Hemoperfusion Price by Application
        5.3.1 Global Hemoperfusion Price by Application (2017-2022)
        5.3.2 Global Hemoperfusion Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Hemoperfusion Market Size by Type
        6.1.1 North America Hemoperfusion Sales by Type (2017-2028)
        6.1.2 North America Hemoperfusion Revenue by Type (2017-2028)
    6.2 North America Hemoperfusion Market Size by Application
        6.2.1 North America Hemoperfusion Sales by Application (2017-2028)
        6.2.2 North America Hemoperfusion Revenue by Application (2017-2028)
    6.3 North America Hemoperfusion Market Size by Country
        6.3.1 North America Hemoperfusion Sales by Country (2017-2028)
        6.3.2 North America Hemoperfusion Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Hemoperfusion Market Size by Type
        7.1.1 Europe Hemoperfusion Sales by Type (2017-2028)
        7.1.2 Europe Hemoperfusion Revenue by Type (2017-2028)
    7.2 Europe Hemoperfusion Market Size by Application
        7.2.1 Europe Hemoperfusion Sales by Application (2017-2028)
        7.2.2 Europe Hemoperfusion Revenue by Application (2017-2028)
    7.3 Europe Hemoperfusion Market Size by Country
        7.3.1 Europe Hemoperfusion Sales by Country (2017-2028)
        7.3.2 Europe Hemoperfusion Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Hemoperfusion Market Size by Type
        8.1.1 Asia Pacific Hemoperfusion Sales by Type (2017-2028)
        8.1.2 Asia Pacific Hemoperfusion Revenue by Type (2017-2028)
    8.2 Asia Pacific Hemoperfusion Market Size by Application
        8.2.1 Asia Pacific Hemoperfusion Sales by Application (2017-2028)
        8.2.2 Asia Pacific Hemoperfusion Revenue by Application (2017-2028)
    8.3 Asia Pacific Hemoperfusion Market Size by Region
        8.3.1 Asia Pacific Hemoperfusion Sales by Region (2017-2028)
        8.3.2 Asia Pacific Hemoperfusion Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Hemoperfusion Market Size by Type
        9.1.1 Latin America Hemoperfusion Sales by Type (2017-2028)
        9.1.2 Latin America Hemoperfusion Revenue by Type (2017-2028)
    9.2 Latin America Hemoperfusion Market Size by Application
        9.2.1 Latin America Hemoperfusion Sales by Application (2017-2028)
        9.2.2 Latin America Hemoperfusion Revenue by Application (2017-2028)
    9.3 Latin America Hemoperfusion Market Size by Country
        9.3.1 Latin America Hemoperfusion Sales by Country (2017-2028)
        9.3.2 Latin America Hemoperfusion Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Hemoperfusion Market Size by Type
        10.1.1 Middle East and Africa Hemoperfusion Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Hemoperfusion Revenue by Type (2017-2028)
    10.2 Middle East and Africa Hemoperfusion Market Size by Application
        10.2.1 Middle East and Africa Hemoperfusion Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Hemoperfusion Revenue by Application (2017-2028)
    10.3 Middle East and Africa Hemoperfusion Market Size by Country
        10.3.1 Middle East and Africa Hemoperfusion Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Hemoperfusion Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Jafron Biomedical
        11.1.1 Jafron Biomedical Corporation Information
        11.1.2 Jafron Biomedical Overview
        11.1.3 Jafron Biomedical Hemoperfusion Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Jafron Biomedical Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Jafron Biomedical Recent Developments
    11.2 Baxter (Gambro)
        11.2.1 Baxter (Gambro) Corporation Information
        11.2.2 Baxter (Gambro) Overview
        11.2.3 Baxter (Gambro) Hemoperfusion Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Baxter (Gambro) Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Baxter (Gambro) Recent Developments
    11.3 Asahi-Kasei
        11.3.1 Asahi-Kasei Corporation Information
        11.3.2 Asahi-Kasei Overview
        11.3.3 Asahi-Kasei Hemoperfusion Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Asahi-Kasei Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Asahi-Kasei Recent Developments
    11.4 Biosun Medical
        11.4.1 Biosun Medical Corporation Information
        11.4.2 Biosun Medical Overview
        11.4.3 Biosun Medical Hemoperfusion Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Biosun Medical Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Biosun Medical Recent Developments
    11.5 Kaneka
        11.5.1 Kaneka Corporation Information
        11.5.2 Kaneka Overview
        11.5.3 Kaneka Hemoperfusion Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Kaneka Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Kaneka Recent Developments
    11.6 Toray Medical
        11.6.1 Toray Medical Corporation Information
        11.6.2 Toray Medical Overview
        11.6.3 Toray Medical Hemoperfusion Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Toray Medical Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Toray Medical Recent Developments
    11.7 Cytosorbents
        11.7.1 Cytosorbents Corporation Information
        11.7.2 Cytosorbents Overview
        11.7.3 Cytosorbents Hemoperfusion Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Cytosorbents Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Cytosorbents Recent Developments
    11.8 Aier
        11.8.1 Aier Corporation Information
        11.8.2 Aier Overview
        11.8.3 Aier Hemoperfusion Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Aier Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Aier Recent Developments
    11.9 Zibo Kangbei
        11.9.1 Zibo Kangbei Corporation Information
        11.9.2 Zibo Kangbei Overview
        11.9.3 Zibo Kangbei Hemoperfusion Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Zibo Kangbei Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Zibo Kangbei Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Hemoperfusion Industry Chain Analysis
    12.2 Hemoperfusion Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Hemoperfusion Production Mode & Process
    12.4 Hemoperfusion Sales and Marketing
        12.4.1 Hemoperfusion Sales Channels
        12.4.2 Hemoperfusion Distributors
    12.5 Hemoperfusion Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Hemoperfusion Industry Trends
    13.2 Hemoperfusion Market Drivers
    13.3 Hemoperfusion Market Challenges
    13.4 Hemoperfusion Market Restraints
14 Key Findings in The Global Hemoperfusion Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Hemoperfusion Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Activated Carbon Adsorption
    Table 3. Major Manufacturers of Resin Adsorption
    Table 4. Global Hemoperfusion Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Hemoperfusion Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Hemoperfusion Sales by Region (2017-2022) & (K Units)
    Table 7. Global Hemoperfusion Sales Market Share by Region (2017-2022)
    Table 8. Global Hemoperfusion Sales by Region (2023-2028) & (K Units)
    Table 9. Global Hemoperfusion Sales Market Share by Region (2023-2028)
    Table 10. Global Hemoperfusion Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Hemoperfusion Revenue Market Share by Region (2017-2022)
    Table 12. Global Hemoperfusion Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Hemoperfusion Revenue Market Share by Region (2023-2028)
    Table 14. Global Hemoperfusion Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Hemoperfusion Sales Share by Manufacturers (2017-2022)
    Table 16. Global Hemoperfusion Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Hemoperfusion Revenue Share by Manufacturers (2017-2022)
    Table 18. Hemoperfusion Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Hemoperfusion Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Hemoperfusion by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoperfusion as of 2021)
    Table 21. Hemoperfusion Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Hemoperfusion Product Offered
    Table 23. Date of Manufacturers Enter into Hemoperfusion Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Hemoperfusion Sales by Type (2017-2022) & (K Units)
    Table 26. Global Hemoperfusion Sales by Type (2023-2028) & (K Units)
    Table 27. Global Hemoperfusion Sales Share by Type (2017-2022)
    Table 28. Global Hemoperfusion Sales Share by Type (2023-2028)
    Table 29. Global Hemoperfusion Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Hemoperfusion Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Hemoperfusion Revenue Share by Type (2017-2022)
    Table 32. Global Hemoperfusion Revenue Share by Type (2023-2028)
    Table 33. Hemoperfusion Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Hemoperfusion Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Hemoperfusion Sales by Application (2017-2022) & (K Units)
    Table 36. Global Hemoperfusion Sales by Application (2023-2028) & (K Units)
    Table 37. Global Hemoperfusion Sales Share by Application (2017-2022)
    Table 38. Global Hemoperfusion Sales Share by Application (2023-2028)
    Table 39. Global Hemoperfusion Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Hemoperfusion Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Hemoperfusion Revenue Share by Application (2017-2022)
    Table 42. Global Hemoperfusion Revenue Share by Application (2023-2028)
    Table 43. Hemoperfusion Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Hemoperfusion Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Hemoperfusion Sales by Type (2017-2022) & (K Units)
    Table 46. North America Hemoperfusion Sales by Type (2023-2028) & (K Units)
    Table 47. North America Hemoperfusion Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Hemoperfusion Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Hemoperfusion Sales by Application (2017-2022) & (K Units)
    Table 50. North America Hemoperfusion Sales by Application (2023-2028) & (K Units)
    Table 51. North America Hemoperfusion Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Hemoperfusion Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Hemoperfusion Sales by Country (2017-2022) & (K Units)
    Table 54. North America Hemoperfusion Sales by Country (2023-2028) & (K Units)
    Table 55. North America Hemoperfusion Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Hemoperfusion Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Hemoperfusion Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Hemoperfusion Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Hemoperfusion Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Hemoperfusion Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Hemoperfusion Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Hemoperfusion Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Hemoperfusion Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Hemoperfusion Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Hemoperfusion Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Hemoperfusion Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Hemoperfusion Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Hemoperfusion Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Hemoperfusion Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Hemoperfusion Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Hemoperfusion Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Hemoperfusion Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Hemoperfusion Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Hemoperfusion Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Hemoperfusion Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Hemoperfusion Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Hemoperfusion Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Hemoperfusion Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Hemoperfusion Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Hemoperfusion Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Hemoperfusion Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Hemoperfusion Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Hemoperfusion Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Hemoperfusion Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Hemoperfusion Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Hemoperfusion Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Hemoperfusion Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Hemoperfusion Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Hemoperfusion Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Hemoperfusion Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Hemoperfusion Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Hemoperfusion Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Hemoperfusion Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Hemoperfusion Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Hemoperfusion Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Hemoperfusion Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Hemoperfusion Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Hemoperfusion Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Hemoperfusion Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Hemoperfusion Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Hemoperfusion Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Hemoperfusion Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Hemoperfusion Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Hemoperfusion Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Jafron Biomedical Corporation Information
    Table 106. Jafron Biomedical Description and Major Businesses
    Table 107. Jafron Biomedical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. Jafron Biomedical Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Jafron Biomedical Recent Developments
    Table 110. Baxter (Gambro) Corporation Information
    Table 111. Baxter (Gambro) Description and Major Businesses
    Table 112. Baxter (Gambro) Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Baxter (Gambro) Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Baxter (Gambro) Recent Developments
    Table 115. Asahi-Kasei Corporation Information
    Table 116. Asahi-Kasei Description and Major Businesses
    Table 117. Asahi-Kasei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Asahi-Kasei Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Asahi-Kasei Recent Developments
    Table 120. Biosun Medical Corporation Information
    Table 121. Biosun Medical Description and Major Businesses
    Table 122. Biosun Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Biosun Medical Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Biosun Medical Recent Developments
    Table 125. Kaneka Corporation Information
    Table 126. Kaneka Description and Major Businesses
    Table 127. Kaneka Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Kaneka Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Kaneka Recent Developments
    Table 130. Toray Medical Corporation Information
    Table 131. Toray Medical Description and Major Businesses
    Table 132. Toray Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Toray Medical Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Toray Medical Recent Developments
    Table 135. Cytosorbents Corporation Information
    Table 136. Cytosorbents Description and Major Businesses
    Table 137. Cytosorbents Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Cytosorbents Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Cytosorbents Recent Developments
    Table 140. Aier Corporation Information
    Table 141. Aier Description and Major Businesses
    Table 142. Aier Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Aier Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Aier Recent Developments
    Table 145. Zibo Kangbei Corporation Information
    Table 146. Zibo Kangbei Description and Major Businesses
    Table 147. Zibo Kangbei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. Zibo Kangbei Hemoperfusion Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Zibo Kangbei Recent Developments
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. Hemoperfusion Distributors List
    Table 153. Hemoperfusion Customers List
    Table 154. Hemoperfusion Market Trends
    Table 155. Hemoperfusion Market Drivers
    Table 156. Hemoperfusion Market Challenges
    Table 157. Hemoperfusion Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hemoperfusion Product Picture
    Figure 3. Global Hemoperfusion Market Share by Type in 2021 & 2028
    Figure 3. Activated Carbon Adsorption Product Picture
    Figure 4. Resin Adsorption Product Picture
    Figure 5. Global Hemoperfusion Market Share by Application in 2021 & 2028
    Figure 6. Hepatic Encephalopathy
    Figure 7. Certain Autoimmune Diseases
    Figure 8. Drug Overdose
    Figure 9. Specific Intoxications
    Figure 10. Others
    Figure 11. Hemoperfusion Report Years Considered
    Figure 12. Global Hemoperfusion Sales 2017-2028 (K Units)
    Figure 13. Global Hemoperfusion Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Hemoperfusion Revenue 2017-2028 (US$ Million)
    Figure 15. Global Hemoperfusion Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Hemoperfusion Sales Market Share by Region (2017-2022)
    Figure 17. Global Hemoperfusion Sales Market Share by Region (2023-2028)
    Figure 18. North America Hemoperfusion Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Hemoperfusion Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Hemoperfusion Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Hemoperfusion Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Hemoperfusion Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Hemoperfusion Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Hemoperfusion Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Hemoperfusion Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Hemoperfusion Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Hemoperfusion Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Hemoperfusion Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Hemoperfusion in the World: Market Share by Hemoperfusion Revenue in 2021
    Figure 30. Global Hemoperfusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Hemoperfusion Sales Market Share by Type (2017-2028)
    Figure 32. Global Hemoperfusion Revenue Market Share by Type (2017-2028)
    Figure 33. Global Hemoperfusion Sales Market Share by Application (2017-2028)
    Figure 34. Global Hemoperfusion Revenue Market Share by Application (2017-2028)
    Figure 35. North America Hemoperfusion Sales Market Share by Type (2017-2028)
    Figure 36. North America Hemoperfusion Revenue Market Share by Type (2017-2028)
    Figure 37. North America Hemoperfusion Sales Market Share by Application (2017-2028)
    Figure 38. North America Hemoperfusion Revenue Market Share by Application (2017-2028)
    Figure 39. North America Hemoperfusion Sales Share by Country (2017-2028)
    Figure 40. North America Hemoperfusion Revenue Share by Country (2017-2028)
    Figure 41. U.S. Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Hemoperfusion Sales Market Share by Type (2017-2028)
    Figure 44. Europe Hemoperfusion Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Hemoperfusion Sales Market Share by Application (2017-2028)
    Figure 46. Europe Hemoperfusion Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Hemoperfusion Sales Share by Country (2017-2028)
    Figure 48. Europe Hemoperfusion Revenue Share by Country (2017-2028)
    Figure 49. Germany Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 50. France Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Hemoperfusion Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Hemoperfusion Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Hemoperfusion Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Hemoperfusion Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Hemoperfusion Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Hemoperfusion Revenue Share by Region (2017-2028)
    Figure 60. China Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 63. India Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 65. China Taiwan Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Hemoperfusion Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Hemoperfusion Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Hemoperfusion Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Hemoperfusion Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Hemoperfusion Sales Share by Country (2017-2028)
    Figure 74. Latin America Hemoperfusion Revenue Share by Country (2017-2028)
    Figure 75. Mexico Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Hemoperfusion Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Hemoperfusion Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Hemoperfusion Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Hemoperfusion Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Hemoperfusion Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Hemoperfusion Revenue Share by Country (2017-2028)
    Figure 84. Turkey Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Hemoperfusion Revenue (2017-2028) & (US$ Million)
    Figure 87. Hemoperfusion Value Chain
    Figure 88. Hemoperfusion Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed